SJJ Solutions develops specialized injection solutions for small-volume injections. Our products are designed to support accurate dosing, efficient preparation, and improved patient safety. Through focused engineering and evidence-based design, we provide drug delivery systems that address the practical challenges of small-volume injection workflows. Working closely with clinicians, we continuously refine our technologies to meet the demands of daily clinical practice and current regulatory standards.
Sever Pharma Solutions
Sever Pharma Solutions is a full-service CDMO specializing in advanced polymer drug products and packaging, including high-potent APIs. We focus on cost-efficient development and reliable large-scale production of high-value products. Our experts in polymers and extrusion design robust, scalable delivery systems, supported by a dedicated Hot Melt Extrusion team in the USA.
Scientific Solutions, LLC
Full-service histology lab providing quality histology and pathology evaluation for GLP and non-GLP preclinical and clinical studies. Long term archiving of study materials.
Rommelag USA
BLOW-FILL-SEAL ADVANCED ASEPTIC LIQUID PACKAGING Rommelag® provides Advanced Aseptic liquid packaging solutions with its Blow/Fill/Seal technology. BFS is the standard packaging technology for preservative-free unit-dose ophthalmic drugs. It has the highest Aseptic Assurance Level available. BFS is now available with Preservative Free Multi-Dose (PFMD) formats. mail.romus@rommelag.com or visit us at www.rommelag.com
RetinAI
About Ikerian AG and RetinAI Inc. U.S. Established in 2017, Ikerian AG (formerly RetinAI Medical AG) and its subsidiary, RetinAI U.S. Inc. (‘Ikerian’, ‘RetinAI’ and, together, ‘the company’), develops software solutions to accelerate clinical, research and pharmaceutical workflows globally using advanced machine learning and computer vision. Focused on the ophthalmology and optometry market, RetinAI builds tools to collect, organize and analyze health data from the eyes, enabling healthcare professionals to make the right decisions sooner in healthcare. RetinAI’s international team leverages its clinical, technical, and scientific expertise to foster the transition from reactive to preventive medicine for severe eye diseases. A commercial stage company with growing sales from RetinAI Discovery®, RetinAI has established collaborations and partnerships with leading ophthalmology clinical networks and pharmaceutical companies.